Effect of topical prostaglandins on the biomechanics and shape of the cornea
Authors:
- 10 August 2019
- journal article
- research article
- Published by Springer Nature in Graefe's Archive for Clinical and Experimental Ophthalmology
- Vol. 257 (10) , 2213-2219
Abstract
Purpose To investigate the effect of topical prostaglandin (PG) eyedrops on the biomechanics and shape of the cornea. Methods Consecutive patients with primary open-angle glaucoma who had been treated with the same anti-glaucoma PG (114 eyes, 57 patients) or β-blocker (36 eyes, 18 patients) eyedrops in 1 eye alone for more than 3 months at Inouye Eye Hospital or Miyata Eye Hospital. The biomechanical properties of the cornea were measured using a Corvis ST device (Oculus, Wetzlar, Germany). Corneal tomography was measured with a Casia 1 or 2 (Tomey Corp., Nagoya, Japan). The biomechanical parameters and tomographic features of the cornea were compared between PG-treated eyes, β-blocker-treated eyes, and contralateral eyes using a mixed-effect model adjusted for intraocular pressure and corneal thickness and a linear model adjusted for age, sex, intraocular pressure, and corneal thickness. Results The PG-treated eyes had a significantly smaller applanation 1 time, the highest concavity radius, and a larger deformation amplitude than the contralateral eyes. Also, the PG-treated eyes had a significantly smaller applanation 1 time and applanation 2 velocity but a larger peak distance than the β-blocker-treated eyes. There were no significant differences in any of the Casia parameters between the PG-treated eyes and the contralateral eyes. Conclusion The results of this study suggest that topical PG makes biochemical changes to the cornea but does not alter its shape.Keywords
This publication has 17 references indexed in Scilit:
- The impact of chronic use of prostaglandin analogues on the biomechanical properties of the cornea in patients with primary open-angle glaucomaBritish Journal of Ophthalmology, 2016
- Corneal Deformation Response in Patients With Primary Open-Angle Glaucoma and in Healthy Subjects Analyzed by Corvis STInvestigative Ophthalmology & Visual Science, 2015
- Elevated Expression of Matrix Metalloproteinase-9 and Inflammatory Cytokines in Keratoconus Patients Is Inhibited by Cyclosporine AInvestigative Ophthalmology & Visual Science, 2015
- Biomechanical Responses of Healthy and Keratoconic Corneas Measured Using a Noncontact Scheimpflug-Based TonometerInvestigative Ophthalmology & Visual Science, 2014
- Effect of prostaglandin analogues on tear proteomics and expression of cytokines and matrix metalloproteinases in the conjunctiva and corneaExperimental Eye Research, 2012
- Effect of Latanoprost on the Expression of Matrix Metalloproteinases and Tissue Inhibitor of Metalloproteinase 1 on the Ocular SurfaceArchives of Ophthalmology (1950), 2010
- Update on the Mechanism of Action of Topical Prostaglandins for Intraocular Pressure ReductionSurvey of Ophthalmology, 2008
- A case of keratoconus progression associated with the use of topical latanoprostJapanese Journal of Ophthalmology, 2008
- Inflammatory Molecules in the Tears of Patients with KeratoconusOphthalmology, 2005
- Latanoprost Stimulates Secretion of Matrix Metalloproteinases in Tenon Fibroblasts Both In Vitro and In VivoInvestigative Ophthalmology & Visual Science, 2003